Microsoft Word - MDA_Q2 2017-in Eng Rev1 HPIR015/2017 Aug 10, 2017 Subject : Management Discussion and Analysis for the period ended June 30,2017 To : The President The Stock Exchange of Thailand
Microsoft Word - MDA_Q2 2017-in Eng Rev1 แก้ไข HPIR015/2017 Aug 10, 2017 Subject : Management Discussion and Analysis for the period ended June 30,2017 To : The President The Stock Exchange of
Page 1 of 4 No. RJH – SET 12/2017 11 Aug 2017 Subject : Management Discussion and Analysis for the 2nd Quarter of 2017 ending on 30 June 2017 To : The President The Stock Exchange of Thailand
14 August 2019 Subject: Management Discussion and Analysis for the 6-Month Period Ended June 30, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public Company
14 November 2019 Subject: Management Discussion and Analysis for the 9-Month Period Ended September 30, 2019 To: Directors and Managers The Stock Exchange of Thailand Halcyon Technology Public
-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana
inventory of Baht 12.81 million and increase in other current assets and other non-current assets of Baht 0.49 million but decrease in deferred income tax of Baht 0.77 million, there were decrease in fixed
-1- AIT (VP-SEC) 018E/2018 August 9, 2018 Subject: Management's Discussion and Analysis of Operating Results for Q2-2018 To: The President of The Stock Exchange of Thailand Summary of Operations Q2
November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries